Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ADORA1 | P30542 | 3/20 | 0.51 |
| ▸ | UBA6 | A0AVT1 | 1/20 | 0.49 |
| ▸ | ATG7 | O95352 | 1/20 | 0.49 |
| ▸ | UBA7 | P41226 | 1/20 | 0.49 |
| ▸ | NAE1 | Q13564 | 1/20 | 0.49 |
| ▸ | UBA3 | Q8TBC4 | 1/20 | 0.49 |
| ▸ | SAE1 | Q9UBE0 | 1/20 | 0.49 |
| ▸ | ADORA3 | P0DMS8 | 1/20 | 0.49 |
| ▸ | RNASEL | Q05823 | 4/20 | 0.48 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL10867600 | 0.91 | ADORA1 (0.59) | ADORA1UBA6ATG7UBA7NAE1 | |
| SCHEMBL7902980 | 0.88 | ADORA1 (0.51) | ADORA1UBA6ATG7UBA7NAE1 | |
| SCHEMBL7906330 | 0.85 | ADORA1 (0.49) | ADORA1ADORA3RNASEL | |
| SCHEMBL7904285 | 0.85 | ADORA1 (0.52) | ADORA1UBA6ATG7UBA7NAE1 | |
| SCHEMBL7906331 | 0.84 | ADORA1 (0.54) | ADORA1ADORA3RNASEL | |
| SCHEMBL7896946 | 0.84 | ADORA1 (0.53) | ADORA1ADORA3RNASEL | |
| SCHEMBL7902992 | 0.83 | ADORA1 (0.51) | ADORA1ADORA3RNASEL | |
| SCHEMBL7896942 | 0.82 | ADORA1 (0.55) | ADORA1ADORA3RNASEL | |
| SCHEMBL7906337 | 0.81 | HSPA5 (0.62) | ADORA1ADORA3RNASEL | |
| SCHEMBL7902955 | 0.81 | ADORA1 (0.58) | ADORA1ADORA3RNASEL |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-RE37077-E1 | Adenosine derivatives and pharmaceutical composition thereof | NIPPON ZOKI PHARMACEUTICAL CO., LTD. (JP) | 2001-02-27 | — | — | US | disclosed |